sur Tharimmune, Inc.
Tharimmune to Engage Investors at Two Major Conferences in May
Tharimmune, Inc., a NASDAQ-listed biotechnology company specializing in inflammation and immunology therapies, announced their participation in two significant investor conferences set for May 2024. CEO Randy Milby will lead presentations and host one-on-one meetings with investors during these events.
The first conference, the Planet MicroCap Showcase: VEGAS 2024, will occur on May 1st at the Paris Hotel & Casino in Las Vegas, Nevada, starting at 3:30 p.m. Pacific Time. Interested parties can register for the conference on its official web page.
Following this, Tharimmune will partake in the EF Hutton Annual Global Conference in New York City. This event is scheduled for May 15th at The Plaza Hotel, where Milby will again engage in one-on-one discussions with attendees. Both events highlight Tharimmune’s proactive approach to engaging with potential investors and partners.
R. P.Copyright © 2024 FinanzWire, tous droits de reproduction et de représentation réservés. Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de Tharimmune, Inc.